159 related articles for article (PubMed ID: 33416407)
1. The association between non-steroidal anti-inflammatory drugs (NSAIDs) and myelodysplastic syndromes in the Adults in Minnesota with Myelodysplastic Syndromes (AIMMS) Study.
Hubbard AK; Richardson M; Rosesler MA; Cioc A; Nguyen PL; Warlick E; Poynter JN
Leuk Lymphoma; 2021 Jun; 62(6):1474-1481. PubMed ID: 33416407
[TBL] [Abstract][Full Text] [Related]
2. Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study.
Poynter JN; Richardson M; Roesler M; Blair CK; Hirsch B; Nguyen P; Cioc A; Cerhan JR; Warlick E
Int J Cancer; 2017 Jan; 140(1):23-33. PubMed ID: 27603749
[TBL] [Abstract][Full Text] [Related]
3. Alcohol use is not a significant contributor to myelodysplastic syndromes.
Duffy EA; Nguyen PL; Cioc A; Warlick E; Roesler MA; Poynter JN
Cancer Causes Control; 2020 Jun; 31(6):549-557. PubMed ID: 32285234
[TBL] [Abstract][Full Text] [Related]
4. Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes.
Poynter JN; Richardson M; Blair CK; Roesler MA; Hirsch BA; Nguyen P; Cioc A; Warlick E; Cerhan JR; Ross JA
Cancer Epidemiol; 2016 Feb; 40():134-40. PubMed ID: 26720913
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal anti-inflammatory drug and acetaminophen use and risk of adult myeloid leukemia.
Ross JA; Blair CK; Cerhan JR; Soler JT; Hirsch BA; Roesler MA; Higgins RR; Nguyen PL
Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1741-50. PubMed ID: 21715605
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS).
Yarosh R; Roesler MA; Murray T; Cioc A; Hirsch B; Nguyen P; Warlick E; Poynter JN
Cancer Causes Control; 2021 Mar; 32(3):241-250. PubMed ID: 33392905
[TBL] [Abstract][Full Text] [Related]
7. Personal history of autoimmune disease and other medical conditions and risk of myelodysplastic syndromes.
Linabery AM; Roesler MA; Richardson M; Warlick ED; Nguyen PL; Cioc AM; Poynter JN
Cancer Epidemiol; 2022 Feb; 76():102090. PubMed ID: 34995873
[TBL] [Abstract][Full Text] [Related]
8. Synergism interaction between genetic polymorphisms in drug metabolizing enzymes and NSAIDs on upper gastrointestinal haemorrhage: a multicenter case-control study.
Mallah N; Zapata-Cachafeiro M; Aguirre C; Ibarra-García E; Palacios-Zabalza I; Macías-García F; Piñeiro-Lamas M; Ibáñez L; Vidal X; Vendrell L; Martin-Arias L; Sáinz-Gil M; Velasco-González V; Bacariza-Cortiñas M; Salgado A; Estany-Gestal A; Figueiras A;
Ann Med; 2022 Dec; 54(1):379-392. PubMed ID: 35114859
[TBL] [Abstract][Full Text] [Related]
9. Tea consumption reduces the risk of de novo myelodysplastic syndromes.
Liu P; Zhang M; Jin J; Holman CD
Leuk Res; 2015 Feb; 39(2):164-9. PubMed ID: 25529769
[TBL] [Abstract][Full Text] [Related]
10. Pesticide exposure as a risk factor for myelodysplastic syndromes: a meta-analysis based on 1,942 cases and 5,359 controls.
Jin J; Yu M; Hu C; Ye L; Xie L; Jin J; Chen F; Tong H
PLoS One; 2014; 9(10):e110850. PubMed ID: 25335083
[TBL] [Abstract][Full Text] [Related]
11. The use of nonsteroidal anti-inflammatory drugs and the risk of Barrett's oesophagus.
Thrift AP; Pandeya N; Smith KJ; Green AC; Webb PM; Whiteman DC
Aliment Pharmacol Ther; 2011 Nov; 34(10):1235-44. PubMed ID: 21967506
[TBL] [Abstract][Full Text] [Related]
12. Risk of ischemic stroke associated with non-steroidal anti-inflammatory drugs and paracetamol: a population-based case-control study.
García-Poza P; de Abajo FJ; Gil MJ; Chacón A; Bryant V; García-Rodríguez LA
J Thromb Haemost; 2015 May; 13(5):708-18. PubMed ID: 25611553
[TBL] [Abstract][Full Text] [Related]
13. Association between mitochondrial DNA haplogroup and myelodysplastic syndromes.
Poynter JN; Richardson M; Langer E; Hooten AJ; Roesler M; Hirsch B; Nguyen PL; Cioc A; Warlick E; Ross JA
Genes Chromosomes Cancer; 2016 Sep; 55(9):688-93. PubMed ID: 27121678
[TBL] [Abstract][Full Text] [Related]
14. Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes.
Kristinsson SY; Björkholm M; Hultcrantz M; Derolf ÅR; Landgren O; Goldin LR
J Clin Oncol; 2011 Jul; 29(21):2897-903. PubMed ID: 21690473
[TBL] [Abstract][Full Text] [Related]
15. Non-steroidal anti-inflammatory drug use and cervical cancer risk: a case-control study using the Clinical Practice Research Datalink.
Wilson JC; O'Rorke MA; Cooper JA; Murray LJ; Hughes CM; Gormley GJ; Anderson LA
Cancer Epidemiol; 2013 Dec; 37(6):897-904. PubMed ID: 24042024
[TBL] [Abstract][Full Text] [Related]
16. Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study.
Driver JA; Logroscino G; Lu L; Gaziano JM; Kurth T
BMJ; 2011 Jan; 342():d198. PubMed ID: 21252104
[TBL] [Abstract][Full Text] [Related]
17. Concurrent inflammatory bowel disease and myelodysplastic syndromes.
Harewood GC; Loftus EV; Tefferi A; Tremaine WJ; Sandborn WJ
Inflamm Bowel Dis; 1999 May; 5(2):98-103. PubMed ID: 10338378
[TBL] [Abstract][Full Text] [Related]
18. Factors predicting early mortality after new diagnosis of myelodysplastic syndrome: A population-based study.
Jacobsen AM; Poynter JN; Richardson MR; Nguyen PL; Hirsch B; Cioc A; Roesler MA; Warlick ED
Eur J Haematol; 2019 Jul; 103(1):56-63. PubMed ID: 31058390
[TBL] [Abstract][Full Text] [Related]
19. Use of low-dose aspirin and non-aspirin nonsteroidal anti-inflammatory drugs and risk of glioma: a case-control study.
Gaist D; García-Rodríguez LA; Sørensen HT; Hallas J; Friis S
Br J Cancer; 2013 Mar; 108(5):1189-94. PubMed ID: 23449355
[TBL] [Abstract][Full Text] [Related]
20. Use of paracetamol, low-dose aspirin, or non-aspirin non-steroidal anti-inflammatory drugs and risk of ovarian borderline tumors in Denmark.
Hannibal CG; Dehlendorff C; Kjaer SK
Gynecol Oncol; 2018 Dec; 151(3):513-518. PubMed ID: 30249529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
